Takao Toshiko, Suka Machi, Nishikawa Masako, Yanagisawa Hiroyuki, Ishii Toru
JR East Health Promotion Center, East Japan Railway Company, 2-1-19 Hiromachi, Shinagawa-ku, Tokyo, 140-0005, Japan.
Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Fam Pract. 2025 Feb 7;42(2). doi: 10.1093/fampra/cmae054.
There is a lack of evidence regarding the trajectories of type 2 diabetes until the first clinic visit, including the untreated period after diagnosis.
We aimed to determine the real-world history of type 2 diabetes until the first clinic visit, including the untreated duration, and to assess the effective timing of the therapeutic intervention.
A total of 23,622 nondiabetic Japanese workers with a mean (SD) age of 38.8 (11.5) years were retrospectively followed from 2008 to 2022 for annual health checkups. The trajectories of glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), and body mass index (BMI) until the first clinic visit in diabetes individuals were determined. ROC analysis was performed to assess the contribution of each measure to the first visit.
During a median follow-up of 12.0 years, 1,725 individuals developed type 2 diabetes, of whom 532 individuals visited clinics. HbA1c and FPG trajectories steeply rose in the year before the first clinic visit after their progressive upward trends. ROC analysis showed cutoff values for each measure. As the untreated duration increased, glycemia increased and BMI decreased among individuals who visited clinics.
To prevent the initial worsening of diabetes, early therapeutic intervention is necessary during the increasing trends before the steep rise in glycemia, regardless of the degree of obesity. HbA1c ≥6.5% (47.5 mmol/mol) and an HbA1c ≥0.2% (2.2 mmol/mol)/year increase may be an effective timing for therapeutic intervention.
关于2型糖尿病在首次临床就诊前的病程,包括诊断后的未治疗期,缺乏相关证据。
我们旨在确定2型糖尿病在首次临床就诊前的真实病程,包括未治疗时长,并评估治疗干预的有效时机。
对2008年至2022年期间进行年度健康检查的23622名非糖尿病日本工人进行回顾性随访,这些工人的平均(标准差)年龄为38.8(11.5)岁。确定糖尿病患者首次临床就诊前糖化血红蛋白(HbA1c)、空腹血糖(FPG)和体重指数(BMI)的病程轨迹。进行ROC分析以评估各项指标对首次就诊的贡献。
在中位随访12.0年期间,1725人患2型糖尿病,其中532人就诊。HbA1c和FPG病程轨迹在首次临床就诊前一年呈渐进上升趋势后急剧上升。ROC分析显示了各项指标的临界值。随着未治疗时长增加,就诊患者的血糖升高而BMI降低。
为防止糖尿病最初恶化,无论肥胖程度如何,在血糖急剧上升前的上升趋势期进行早期治疗干预是必要的。HbA1c≥6.5%(47.5 mmol/mol)且HbA1c每年升高≥0.2%(2.2 mmol/mol)可能是治疗干预的有效时机。